Category: MRSAid For Nasal Decolonization

MRSAid Is Live-blogging from Canada’s Leading Microbiology and Infectious Disease Conference

9:04am: Today, the MRSAid team is live-blogging from the AMMI-CACMID annual conference. If you are one of Canada’s top clinical microbiologists or infectious disease specialists, this is THE place to be. We’re very excited to be attending this conference for the first time, and can’t wait to speak w/ some of the top professionals in the country.

10:18am: The AMMI-CACMID conference is meant to bring together students and professionals in the areas of microbiology, antimicrobial stewardship, infectious diseases, infection prevention and control, and public health. Judging by the turnout at the opening lecture, they’ve certainly done a great job bringing these people together. Just check out the packed room!

10:42am: Lectures this morning have been incredibly interesting and it is clear from the talks that MRSA problem is not going away. In fact, MRSA colonization rates in high-risk patients have been as high as 15%! Read More

Over 2,500 patients treated at VGH using MRSAid™

Our MRSAid™ Photodisinfection procedure has been well received at VGH and represents a promising approach to improve patient safety in other healthcare facility settings… Photodisinfection (is) ideal for hospital settings as it eliminates the need for patient compliance as it can be administered just prior to surgery- Carolyn Cross, Chairman and CEO of Ondine.

Less than a year ago, Vancouver General Hospital implemented the MRSAid™ Photodisinfection System as part of a year-long infection control Quality Improvement Project. Since then, we are very pleased to announce that we have treated over 2,500 patients, making this one of the largest PDT studies in the world. The project is being undertaken with the objective of reducing the incidence of surgical site infections in selected surgical populations.

Many people do not know that the nose is the primary site for bacteria colonization. The average person touches their nose more than 100 times a day, and if they touch their nose and then touch their surgical site, they are at risk of giving themselves an infection that was completely preventable. Many studies have demonstrated a significant reduction in surgical site infections after nasal decolonization of both Staph and MRSA. It is therefore critical to continue the development of non-antibiotic treatments that eliminate potentially deadly bacteria from the nose.

Read More

Nurses Explain How MRSAid Can Change The Way We Look At Healthcare

We have a new video! Three fantastic nurses describe how MRSAid works & how it can help prevent surgical site infections. In a report from the CDC, of the over 1.7 million healthcare-associated infections occurring annually, surgical site infections are one of the most predominant infections (290,485).* Watch the video below to learn how MRSAid can change the process of controlling healthcare-associated infections.

*Scott RD, CDC. The Direct Medical COsts of Healthcare-Associated Infections in US Hospitals and the Benefits of Prevention, March 2009.

Rapid MRSA Diagnosis needs Rapid MRSA Decolonization Therapeutics

There are several companies which offer rapid diagnostic tests for a drug-resistant staph infection known as MRSA (Methicillin-resistant Staphylococcus aureus), one of the most common superbugs found in hospitals. The Centers for Disease Control and Prevention (CDC) states that MRSA affects 90,000 Americans each year, killing about 18,000.

Rapid diagnosis of MRSA enables a healthcare facility to quickly determine if a new patient is colonized with MRSA and would enable intervention measures to be deployed more quickly. Rapid diagnosis is expected to therefore reduce  the spread of MRSA to other patients via healthcare workers who are seen to be the usual vector of transmission across the healthcare facilities. Deployment measures would include isolation chambers, full gown & glove protocols, hand washing before and after patient visits etc.  An additional use of MRSA diagnostics is the opportunity to apply intervention measures to  prevent surgical site infections since MRSA carriers run the risk of self-infection once their bodies are immuno-compromised after a surgery.

Read More

Dr. Cale Street Profiled On National TV Via CEO Clips

MRSAidTM would like to congratulate Dr. Cale Street on being profiled on CEO Clips where he discusses the severity of Healthcare-Associated Infections (HAIs) and future plans for MRSAidTM.  Dr. Street touches upon the seriousness of superbugs that are becoming resistant to antibiotics and subsequently resulting in difficult to treat HAIs.

MRSAidTM is currently being used at Vancouver General Hospital for patients undergoing select surgeries in order to reduce the risk of developing post-surgical site infections.  Since MRSAidTM does not generate bacterial resistance, this is a milestone in the fight against HAIs and antibiotic resistant superbugs. Watch the video below:

VGH Infection Control Project & MRSAid™ Featured on Canadian National News!

A few days ago, we announced an innovative partnership with one of Canada`s largest hospitals, Vancouver General Hospital (VGH). We are very excited to have this partnership featured on Global News.

Pathogenic bacteria such as Staphylococcus aureus and MRSA can significantly increase the risk of a patient developing serious infections after surgery. MRSAidTM is a non-antibiotic therapy designed to eliminate bacteria in the noses of patients during high infection risk times. As part of our partnership with VGH, MRSAidTM will be used on patients undergoing cardiac, spinal, breast reconstruction, thoracic, neurological, and orthopaedic surgeries. We are very excited to be working with the leaders in infection control at VGH. For more information on MRSAidTM, please visit www.mrsaid.com. Also, please connect with us on TwitterFacebook, we`ll be happy to respond to any comments and questions.

MRSAid™ To Be Implemented at Vancouver General Hospital as Part of Infection Control Project

MRSAid product images by Ondine BiomedicalEvery year on April 7th, we celebrate World Health Day to mark the founding of the World Health Organization (WHO). Under this year’s theme of “Combating Drug Resistance,” the WHO is challenging healthcare professionals around the world to take action and implement change to address the growing problem of antibiotic resistance. Ondine is pleased to be able to respond to this challenge by entering into an innovative partnership with one of Canada’s largest hospital to introduce a novel non-antibiotic decolonization therapy aimed at reducing hospital-acquired infections (HAI’s).

Read More

MRSAid™ FOR NASAL DECOLONIZATION

Staphylococcus aureus, especially Methicillin-Resistant Staphylococcus aureus (MRSA), infections can be severe and even fatal.  Each year, thousands of patients acquire Staph infections annually while in hospital resulting in enormous suffering, amputations and loss of life. Studies throughout North America and the UK have demonstrated that patients who are carrying or are colonized with Staphylococcus aureus are at risk of self-infecting. Studies also have demonstrated that eliminating nasal carriage of Staphylococcus aureus significantly reduces the number of Staph infections and therefore must be considered a necessary strategy for the overall reduction of healthcare-associated infections.1,2

The nose, armpits, hand and groin are the major hotspots for MRSA colonization

Read More

Introduction To Photodynamic Medicine

The light diffusing tip delivers light to the treatment area, powering the photodynamic reaction without heat or generating resistance

The light diffusing tip delivers light to the treatment area, powering the photodynamic reaction without heat or generating resistance

“There are two kinds of light — the glow that illumines, and the glare that obscures…”

In 1963, James Thurber was almost certainly unaware of photodynamic medicine when he authored that quote, or else he might have added a 3rd type of light – the glimmer that heals. Loosely put, the word photodynamic means using light to cause an action or effect.  This definition, though simple, succinctly summarizes the concept of photodynamic medicine – a set of therapies that leverages visible light to create a targeted, potent effect. So how can simple light in the range of red to violet (the kind we can see) generate a clinical effect?  Save for a select group of therapies, some more reputable than others, it cannot…on its own. Read More

The Case For Photodisinfection

Biofilm Stages of Development - Source: Wiki Commons

Humans are multicellular creatures each comprised of trillions of cells. Oddly enough, bacteria in our bodies outnumber our human cells by 10:1, although their size is, on average, about one tenth of a human cell. When seen in this light, humans really are part human and part bacteria.  We are dependent on the maintenance of a delicate balance between human cells and bacterial cells for good health as we coexist with bacteria in a symbiotic relationship. There are estimated to be between 500-1,000 species of bacteria living in the human gut and skin.  Some of our bacteria are known to perform certain tasks that are critical. Without our bacteria, for instance, we would be unable to digest and process our food intake.  These commensal bacteria are widely known as our “flora”. Too many of any one kind of bacteria, and we are left in poor health. Bacteria, therefore, play a very important role in human health and human disease.

Read More

Related Posts Plugin for WordPress, Blogger...

Staypressed theme by Themocracy